Category Archives: Compliance

Internal Auditing – Advanced Internal Audit Capabilities (Sweta Shah, April Patterson, Deloitte). Few Quick Takeaways:

Agile and Dynamic Risk Assessment (DRA) are part of the blue print for enabling the internal audit processes of the future. Agile approach to IA: iterative, cross-functional collaboration (e.g., collaborate on identification of risk areas and alignment on what is audited and why), focus on business value and continuous improvement. Cognitive science / Agile approach suggests: The longer we… Read More »

More Highlights from the 2020 HFMA and NEHIA Compliance & Internal Audit Conference

By | December 14, 2020

By Amber Fecik, Manager, Deloitte & Touche LLP and Amelia Abba, Manager, Deloitte & Touche LLP As noted in previous blogs, the MA-RI Chapter of HFMA teamed up with the New England Healthcare Internal Auditors (NEHIA) organization on December 2nd and 3rd to put on NEHIA’s annual Compliance and Internal Audit Conference.  A few additional highlights from the… Read More »

Highlights from the 2020 HFMA and NEHIA Compliance & Internal Audit Conference

By | December 14, 2020

By Amber Fecik, Manager, Deloitte & Touche LLP and Amelia Abba, Manager, Deloitte & Touche LLP The HFMA MA-RI Chapter teamed up with the New England Healthcare Internal Auditors (NEHIA) organization last week to put on NEHIA’s annual Compliance and Internal Audit Conference.  The conference was attended by more than 140 participants and was a great success!  Thank… Read More »

Thank You, Everyone!

By | December 14, 2020

By Dhara Satija, HFMA MA-RI Chapter Board Member & Compliance Committee Co-Chair and Amber Fecik, NEHIA Board Member The HFMA MA-RI Chapter and New England Healthcare Internal Auditors (NEHIA) organization would like to thank all of those who made last week’s virtual Compliance and Internal Audit Conference a success! Thank you to our more than 140 participants who… Read More »

E&M Changes 2021 – What the Changes Mean for Private Practices session by Pam D’Apuzzo, President, RR Health Strategies, LLC

By | December 8, 2020

By: Katherine Record, Executive Director, Beth Israel Lahey Health Medicaid ACOs and Performance Network Compliance & Privacy Strategy, HFMA MA-RI Chapter, Compliance Committee Member, CMS is making changes to E/M codes 99201-99205 and 99211-99215, which are likely to be adopted universally across all payers (including commercial). What do you need to know? For the first time, physical exam… Read More »

Internal Auditing – Operational vs. Clinical Audit session by Scott Brady, Clinical Compliance Auditor and Nick Borges, Compliance Internal Auditor of Lifespan

By | December 8, 2020

By: Garrett Gillespie, Corporate Compliance Officer and Deputy GC, BMC HealthNet Plan; HFMA MA-RI Chapter Compliance Committee Member, What to review to identify risks:  senior management surveys, operational management interviews, regulatory publications (e.g., OIG website), audit staff input, external sources. Audits are won or lost in the preparation.  Think about: What do you need to know? What should… Read More »

The COVID 19 Impact on the Transfer Rule

By | July 27, 2020

As a refresher, under the Post-Acute Transfer Rule (PACT), if a patient was discharged below the Geometric Mean Length of Stay (GMLOS) and the discharge status on the claim indicated a transfer to post-acute care, then the hospital is entitled to a per diem payment amount and not the total amount a full DRG payment would provide. There… Read More »

The OIG Urges CMS to Implement Solutions to Reduce Fraud in Medicare Part C and Part D

By | August 7, 2019

Recently, the Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) issued its 2019 “Solutions to Reduce Fraud, Waste, and Abuse in HHS Programs: Top Unimplemented Recommendations.”  The OIG releases a version of this report each year outlining its top 25 unimplemented recommendations to reduce fraud, waste, and abuse (“FWA”) among HHS programs.  This blog post… Read More »

Drug Pricing and Payment Policy: Key 2018 Developments and Potential 2019 Changes and Challenges

Following a number of drug pricing reforms implemented or proposed in 2018, 2019 likely will bring more action from HHS and Congress to reduce drug prices. Key Points: In 2018, the Administration implemented and proposed several policy changes to reduce drug prices or spending, and Congress passed new legislation prohibiting health plans from preventing pharmacies from informing plan… Read More »

Sponsored Post: Reasons to Be Hopeful About the US Health Industry in 2019

* * * * * This post sponsored by PwC. * * * * * The US health industry is showing signs of modernizing along the lines of tech, retail and hospitality, changes that should benefit consumers and the healthcare system overall. Once thought to operate outside the greater US economy, the industry—with its byzantine payment system, complicated… Read More »